Keya Medical announced that it has completed a $30 Million Series C Funding Round led by IDG Capital, with participation from investors Alwin Capital, Source Code Capital, and Tasly Group.
Dr. Kunlin Cao delivered a keynote address at the China AI in Medical Imaging Conference on Keya Medical’s experience bringing AI-powered medical imaging solutions to clinical use.
On Sept. 18, Keya Medical was recognized as the winner of China’s Most Promising Company award because of its leading R&D team and innovative cardiovascular product line.
On Sept. 10, Keya Medical was invited to deliver an academic lecture to more than 130 imaging departments in honor of the newly established Northern Jiangsu People’s Hospital Medical Imaging Alliance.
Keya Medical announced on Aug. 13 that it has raised over $20 million in Series B+ funding.